
BEIJING -- China's vaccine diplomacy faces a setback as questions arise about the efficacy and safety of its coronavirus inoculations while the country speeds a large-scale rollout despite the candidates remaining in the clinical trial phase.
Beijing once led the global race to develop a COVID-19 vaccine, but U.S. and European pharmaceutical firms are close to bringing candidates to market.